⌘K
t
| Date | 30 May 2025 |
| Time | 07:00:12 |
| Category | Miscellaneous |
| ID | 6954K |
30 May 2025
ProBiotix Health plc
("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")
Notice of Annual General Meeting
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that Notice convening the Company's Annual General Meeting for 11:00 am on 27 June 2025 at the offices of Gerald Edelman, 73 Cornhill, London EC3V 3QQ, will be posted today to shareholders as part of the published accounts and will be available shortly on the Company's website at www.probiotixhealth-ir.com
For further information, please contact:
|
ProBiotix Health plc |
https://probiotixhealth-ir.com/ |
|
|
investors@probiotixhealth.com |
|
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations |
|
|
|
|
|
Peterhouse Capital Limited Aquis Corporate Adviser and Broker |
|
|
Mark Anwyl Duncan Vasey
|
Tel: 020 7469 0930 |
|
|
|
Notes to Editors:
ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a unique approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.